<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Neurogene Inc (NGNE)</title>
    <description>Latest news, press releases, and SEC filings for Neurogene Inc (NGNE)</description>
    <link>https://caymanjournal.com/stock/NGNE</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 21:45:21 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/NGNE/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>8-K — Neurogene Inc.</title>
      <description># 📰 What This Document Is 📣

This filing is an 8-K, which is a required SEC form used to announce major corporate events that shareholders and the public should know about immediately. In simple terms, it’s the company’s way of saying, &quot;Hey, pay attention! We have big news.&quot; The announcement, made</description>
      <link>https://caymanjournal.com/stock/NGNE/sec-filing/0001404644-26-000030</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/NGNE/sec-filing/0001404644-26-000030</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>